Literature DB >> 832270

Characterization and assay of progesterone receptor in human mammary carcinoma.

M F Pichon, E Milgrom.   

Abstract

[3H]Pregn-4-ene-3,20-dione ([3H]progesterone)-receptor complexes from human mammary carcinoma were found to be stabilized in the presence of glycerol. The dissociation rate constant was lowered and the equilibrium dissociation constant was decreased (KD=3 nM in the absence of glycerol and 1.1 nM in the presence of 30% glycerol), whereas no clear-cut effect on the association rate was observed and no change occurred in the concentration of binding sites. Cortisol was found to compete with [3H]progesterone only at concentrations higher than 1 muM. This made it possible to distinguish [3H]progesterone binding to the receptor from binding to corticosteroid-binding globulin. Synthetic progestins [6-chloro-17-acetoxypregna-4,6-diene-3,20-dione (chlromadinone acetate), 17alpha-ethinyl, 17-hydroxyestr-4-en-3-one (norethisterone), and 17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione (R5020)] were found to have a high affinity for the receptor, whereas 5alpha-pregnane-3,20-dione had an affinity about one-half that of progesterone itself 5beta-Pregnane-3,20-dione, 17alpha-hydroxypregn-4-ene-3,20-dione (estradiol), 11beta,21-dihydroxy-pregn-4-ene-3,20-dione (corticosterone), estra-1,3,5(10)-triene-3,17beta-diol, and 17beta-hydroxyandrost-4-en-3-one (testosterone) were weak inhibitors of [3H]progesterone binding. Sedimentation on glycerol gradients showed different patterns in different tumors; i.e., [3H]progesterone specific binding having the characteristics of receptor was found either in the 8 S region, in the 4.5 S region, or in both. Activated progesterone-receptor complex from human mammary carcinoma cytosol was shown to bind to human DNA. An assay of the receptor based on these binding properties is described. This assay measures the total concentration of cytosol receptor since it makes possible the exchange of endogenous hormone for excess added [3H]progesterone. Of 55 biopsies examined by this method, 35 (64%) had a concentration of progesterone receptor-binding sites higher than 10 fmoles/mg protein. There was a positive correlation between the amounts of estrogen and progesterone receptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832270

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis.

Authors:  Namrata Bali; Jason M Arimoto; Nahoko Iwata; Sharon W Lin; Liqin Zhao; Roberta D Brinton; Todd E Morgan; Caleb E Finch
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.

Authors:  S De Placido; C Gallo; A Marinelli; F Perrone; C Pagliarulo; G Petrella; G Delrio; M D'Istria; L Del Mastro; A R Bianco
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

3.  Isoelectric focusing of steroid hormone receptors in slabs of polyacrylamide gel.

Authors:  O Wrange
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

4.  Hormone receptors in breast cancer.

Authors:  J Appelbaum
Journal:  Br Med J       Date:  1978-10-21

5.  A multifactorial analysis of steroid hormone receptors in stages I and II breast cancer.

Authors:  H M Kohail; E G Elias; S A el-Nowiem; N Bashirelahi; M S Didolkar; W P Reed
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

6.  Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.

Authors:  S Gundersen; S Kvinnsland; S Lundgren; O Klepp; E Lund; O Børmer; H Høst
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

7.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.

Authors:  J S Meyer; M Province
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

9.  Evidence for the origin of the unoccupied oestrogen receptor in nuclei of a human breast-cancer cell line (MCF-7).

Authors:  A Geier; M Haimsohn; B Lunenfeld
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

10.  Multiple steroid hormone receptors in normal and abnormal human endometrium.

Authors:  G Prodi; G Nicoletti; C De Giovanni; M C Galli; S Grilli; P Nanni; G Gola; R Rocchetta; C Orlandi
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.